FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Apace Packaging Recalls Shingles Drug

Apace Packaging recalls one lot of shingles therapy acyclovir tablets, USP, 400mg, due to a product mix-up.

Federal Register

Proposed Rule on Animal Drug ADR eSubmissions

Federal Register proposed rule: FDA proposes to amend its postmarketing safety reporting regulations for approved new animal drugs to require that cer...

Human Drugs

Wilson Disease Petition is Moot: FDA

FDA says a petition seeking approval of a generic form of Syprine is moot because the agency has approved an ANDA for the drug.

Human Drugs

Many Regs Proposed for Elimination or Change

Stakeholders give FDA a long list of regulations they believe could be modified or eliminated to reduce administrative burden and promote efficiency.

Human Drugs

Pharmaceutical Co-Crystal Classification Guidance

FDA issues a guidance for NDA and ANDA applicants on the regulatory classification of pharmaceutical co-crystals.

Human Drugs

Clarify Refuse-to-File Guidance: PhRMA

PhRMA wants changes in an FDA draft guidance on refusing to file NDAs and BLAs.

Federal Register

Workshop on Rare Disease Statistical Methods/Trial Designs

Federal Register notice: FDA announces a 3/19 workshop on Utilizing Innovative Statistical Methods and Trial Designs in Rare Disease Settings.

FDA General

FDA Not Strong at Succession Planning: Sherman

FDA principal deputy commissioner Rachel Sherman says the agency has to do a better job of preparing the next generation of staff leaders to take over...

Human Drugs

Janssens Erleada Approved for Prostate Cancer

FDA approves a Janssen NDA for Erleada (apalutamide) for treating patients with prostate cancer that has not spread, but that continues to grow despit...

Federal Register

Regulatory Review Determined for Ibrance

Federal Register notice: FDA determines for patent extension purposes that the regulatory review period for Warner-Lamberts Ibrance (palbociclib) is 3...